This inventor holds 7 USPTO granted patents and 10 published patent applications and 4 EPO patents. Top assignees: The Chinese University of Hong Kong, Grail, Inc.. Active years: 2020-2026.
Location History:
- Hong Kong, CN (2020 - 2022)
- Kowloon, CN (2020 - 2022)
Company Filing History:
6 out of 500 
5 out of 66 
Years Active: 2020-2026
Title: Innovations of Wai Kei Lam in Cancer Screening
Introduction
Wai Kei Lam is a prominent inventor based in Hong Kong, known for his significant contributions to the field of cancer diagnostics. With a total of six patents to his name, he has developed innovative methods that enhance cancer screening and diagnosis through advanced analysis of nucleic acids.
Latest Patents
One of his latest patents focuses on the enhancement of cancer screening using cell-free viral nucleic acids. This invention allows for the analysis of cell-free DNA molecules in biological samples to detect viral DNA. The methylation of viral DNA molecules can be determined, and the mixture methylation levels can be measured in various ways. This method can compare the methylation levels to reference levels from different cohorts, aiding in the classification of whether a subject has a specific condition. Another notable patent involves diagnostic applications using nucleic acid fragments. This invention analyzes the count, fragmentation patterns, and size of cell-free nucleic acids, including those from pathogens. It can determine if a subject has cancer or other pathologies and assess the stage or progression of a condition over time.
Career Highlights
Wai Kei Lam has worked with esteemed institutions, including The Chinese University of Hong Kong and Grail, Inc. His work has significantly impacted the field of cancer diagnostics, showcasing his commitment to advancing medical technology.
Collaborations
He has collaborated with notable colleagues such as Yuk-Ming Dennis Lo and Rossa Wai Kwun Chiu, contributing to the development of innovative diagnostic methods.
Conclusion
Wai Kei Lam's contributions to cancer screening through his innovative patents demonstrate his expertise and dedication to improving healthcare outcomes. His work continues to influence the field of diagnostics, paving the way for future advancements.